MX9304621A - Tensioactivos pulmonares de peptidos sinteticos que tienen antioxidantes unidos covalentemente. - Google Patents

Tensioactivos pulmonares de peptidos sinteticos que tienen antioxidantes unidos covalentemente.

Info

Publication number
MX9304621A
MX9304621A MX9304621A MX9304621A MX9304621A MX 9304621 A MX9304621 A MX 9304621A MX 9304621 A MX9304621 A MX 9304621A MX 9304621 A MX9304621 A MX 9304621A MX 9304621 A MX9304621 A MX 9304621A
Authority
MX
Mexico
Prior art keywords
antioxidants
synthetic peptides
lung surfaces
covalently
united
Prior art date
Application number
MX9304621A
Other languages
English (en)
Inventor
Larry R Mclean
J Vincent Edwards
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of MX9304621A publication Critical patent/MX9304621A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1021—Tetrapeptides with the first amino acid being acidic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Pulmonology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

La invención describe la preparación de tensioactivos pulmonares sintéticos que tienen propiedades antioxidantes que consisten de un complejo de un polipéptido de 3-4 residuos aminoácidos, con una porción antioxidante, y un lípido que consiste de uno o más de los lípidos asociados con el tensioactivo pulmonar natural. Estos tensioactivos son útiles en el tratamiento del síndrome malestar respiratorio.
MX9304621A 1992-07-31 1993-07-30 Tensioactivos pulmonares de peptidos sinteticos que tienen antioxidantes unidos covalentemente. MX9304621A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92309292A 1992-07-31 1992-07-31
US7780293A 1993-06-21 1993-06-21

Publications (1)

Publication Number Publication Date
MX9304621A true MX9304621A (es) 1994-02-28

Family

ID=26759685

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9304621A MX9304621A (es) 1992-07-31 1993-07-30 Tensioactivos pulmonares de peptidos sinteticos que tienen antioxidantes unidos covalentemente.

Country Status (13)

Country Link
US (2) US5623052A (es)
EP (1) EP0652894B1 (es)
JP (1) JPH07509713A (es)
KR (1) KR100279059B1 (es)
AT (1) ATE157671T1 (es)
AU (1) AU664112B2 (es)
CA (1) CA2137348C (es)
DE (1) DE69313647T2 (es)
ES (1) ES2107048T3 (es)
IL (1) IL106503A0 (es)
MX (1) MX9304621A (es)
NZ (1) NZ254496A (es)
WO (1) WO1994003484A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU664112B2 (en) * 1992-07-31 1995-11-02 Merrell Dow Pharmaceuticals Inc. Synthetic peptide lung surfactants having covalently bonded antioxidants
ES2527760T3 (es) * 1998-07-23 2015-01-29 Yeda Research And Development Co., Ltd. Tratamiento de enfermedad de Crohn con copolímero 1 y polipéptidos
IL141021A0 (en) 1998-07-23 2002-02-10 Yeda Res & Dev Treatment of autoimmune conditions with copolymer 1 and related copolymers
US6800287B2 (en) 1998-09-25 2004-10-05 Yeda Research And Development Co., Ltd. Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
US7022663B2 (en) 2000-02-18 2006-04-04 Yeda Research And Development Co., Ltd. Oral, nasal and pulmonary dosage formulations of copolymer 1
US20020077278A1 (en) 2000-06-05 2002-06-20 Yong V. Wee Use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders
WO2002076503A1 (en) 2000-06-20 2002-10-03 Mayo Foundation For Medical Education And Research Treatment of central nervous system diseases by antibodies against glatiramer acetate
EP1307212B1 (en) 2000-07-31 2007-03-28 World Resources Corporation Plant derived antioxidants
US6465432B1 (en) 2000-08-28 2002-10-15 Kraft Food Holdings, Inc. Isolated antioxidant peptides form casein and methods for preparing, isolating, and identifying antioxidant peptides
US7429374B2 (en) 2001-12-04 2008-09-30 Teva Pharmaceutical Industries, Ltd. Process for the measurement of the potency of glatiramer acetate
AU2003223718B2 (en) * 2002-04-25 2007-08-16 The Scripps Research Institute Treatment and prevention of pulmonary conditions
EP1809272A4 (en) * 2004-10-18 2008-01-02 Maroon Biotech Corp METHOD AND COMPOSITIONS FOR TREATING DAMAGES THROUGH FREE RADICALS

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861756A (en) * 1988-03-08 1989-08-29 Merrell Dow Pharmaceuticals Inc. Synthetic pulmonary surfactant
AR245141A1 (es) * 1988-07-01 1993-12-30 Merrell Dow Pharma Procedimiento de sintesis secuencial o de bloques en fase solida para preparar polipeptidos de estructura helicoidal.
FR2676056B1 (fr) * 1991-05-03 1993-07-16 Adir Nouveaux derives du benzopyranne leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
ZA926185B (en) * 1991-08-22 1993-03-01 Merrell Dow Pharma Novel orally-active elastase inhibitors.
US5272252A (en) * 1991-11-04 1993-12-21 Merrell Dow Pharmaceuticals Inc. Synthetic lung surfactant having antioxidant properties
AU664112B2 (en) * 1992-07-31 1995-11-02 Merrell Dow Pharmaceuticals Inc. Synthetic peptide lung surfactants having covalently bonded antioxidants

Also Published As

Publication number Publication date
JPH07509713A (ja) 1995-10-26
EP0652894A1 (en) 1995-05-17
US5623052A (en) 1997-04-22
NZ254496A (en) 1996-08-27
KR950702573A (ko) 1995-07-29
AU4659693A (en) 1994-03-03
DE69313647D1 (de) 1997-10-09
ES2107048T3 (es) 1997-11-16
CA2137348C (en) 2000-11-28
US5886156A (en) 1999-03-23
AU664112B2 (en) 1995-11-02
ATE157671T1 (de) 1997-09-15
DE69313647T2 (de) 1998-03-12
IL106503A0 (en) 1993-11-15
CA2137348A1 (en) 1994-02-17
WO1994003484A1 (en) 1994-02-17
EP0652894B1 (en) 1997-09-03
KR100279059B1 (ko) 2001-01-15

Similar Documents

Publication Publication Date Title
GR3029279T3 (en) Synthetic lung surfactant having antioxidant properties.
MX9304621A (es) Tensioactivos pulmonares de peptidos sinteticos que tienen antioxidantes unidos covalentemente.
CA2113995A1 (en) Use of gentisic acid or gentisyl alcohol for stabilising radiolabeled peptides and proteins
CA2075060A1 (en) Novel vehicle gases and their use in medical preparations
IS5329A (is) Flutningskerfi fyrir antígen þar sem monoglýseríðeða díglýseríð afleiður eru ónæmisglæðar
DK0728148T3 (da) Forbedrede immunogene sammensætninger mod humant gastrin 17
NO304982B1 (no) Fosfolipid, fosfatidyletanolamin, farmas°ytisk, nµrings eller kosmetisk blanding omfattende nevnte fosfolipid eller fosfatidyletanolamin
AR015498A1 (es) Composiciones de edulcorante de mesa.
SE9403526D0 (sv) New Peptides
AU7066087A (en) Synthetic atrial peptides
ES8407012A1 (es) Un procedimiento para la preparacion del derivado peptidico ciclico a-21978c.
ES2114061T3 (es) Surfactantes peptidicos pulmonares y combinaciones terapeuticas.
AU8375891A (en) Antioxidant system based on a basic amino acid in combination with a tocopherol or derivative thereof and a nonthiolated polypeptide, and compositions containing the same
DE3268716D1 (en) Peptides and process for their preparation
EP0490383A3 (en) Peptides of the hiv-gag protein, their preparation and use
ITMI912837A1 (it) Procedimento per preparare prodotti peptidici e/o proteinici arricchiti con amminoacidi legati in modo covalente
MY107451A (en) Cloning and expression of a rhoptry associated protein of p.falciparum
MX9205978A (es) Nuevas proteinas inhibidoras de trombina de garrapatas.
CA2137349A1 (en) Peptide lung surfactants and therapeutic combinations
GB2013210A (en) Therapeutically Useful Pseudopeptides, Compositions Containing the Same and Methods of Preparation and Use
SE9002274D0 (sv) Novel 3,3'-dithiobis(propionic esters).
IT1288020B1 (it) Integratori alimentari e dietetici contenenti gelatina idrolizzata e loro uso in campo medico-sanitario
IT8340120A1 (it) Poltrona in particolare per sale cinematografiche, teatri e simili